UK markets closed

Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
10.14-0.03 (-0.29%)
At close: 03:04PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,927,670
2,865,752
2,331,063
2,168,765
1,701,417
Cost of revenue
621,699
620,344
503,375
432,415
361,080
Gross profit
2,305,971
2,245,408
1,827,688
1,736,350
1,340,337
Operating expenses
Research development
256,480
254,680
166,012
166,539
128,761
Selling general and administrative
929,650
898,609
767,612
841,748
706,804
Total operating expenses
1,309,050
1,279,349
1,015,596
1,106,927
889,550
Operating income or loss
996,921
966,059
812,092
629,423
450,787
Interest expense
2,379
1,874
1,522
1,622
1,619
Income before tax
957,685
919,930
833,848
295,117
416,139
Income tax expense
66,005
61,341
96,192
91,731
69,604
Income from continuing operations
891,680
858,589
737,656
203,386
346,535
Net income
879,361
847,229
703,260
206,629
358,955
Net income available to common shareholders
879,361
847,229
703,260
206,629
358,955
Basic EPS
0.46
0.51
0.43
0.13
0.22
Diluted EPS
0.46
0.51
0.43
0.13
0.22
Basic average shares
1,656,010
1,661,234
1,635,489
1,589,458
1,631,615
Diluted average shares
1,656,010
1,661,234
1,635,489
1,589,458
1,631,615